• Two Innovative Business Areas
  • Six Years of Growth
PRESS

11.08.2022

Medios AG continues record course: Strong growth in the first half of...

Acquisition

Medios acquires NewCo Pharma Group

Medios expands its market position in compounding and taps new growth potentials

Sustainability

Think about tomorrow

Sustainability strategy published – comprehensive Sustainability program to be implemented by 2025

Reporting Center

All Information regarding Corporate Development

Half-Year Financial Report 2022

Annual General Meeting

Annual General Meeting of Medios AG

The Annual General Meeting 2022 of Medios AG will be held on June 21, 2022. Further details will be published here in due course.

Corporate Calender

Dates and Events

Corporate Governance

For Maximum Transparency

Growth Market

Specialty Pharma Medicinal Products

Focus on Patients

Pioneer on the Stock Exchange

Medios AG is one of the best-known companies in the growth market of specialty pharmaceuticals in Germany.

Specialty pharma medicinal products are medicines for patients with rare or chronic diseases such as cancer, HIV, hepatitis or hemophilia.

Our work centers on patient wellbeing.

Medios AG is Germany's first specialty pharmaceutical company to be listed on the stock exchange.

Contact

Claudia Nickolaus
Head of Investor & Public Relations
ESG Communications

 +49 30 232 566 800

 ir@medios.ag

 

Stay informed Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date. 

Registration is free of charge and can be revoked at any time.

Click here to register